The Fundación Mutua Madrileña has announced the allocation of 2.3 million euros to 21 medical research projects across 25 centers in 12 Spanish autonomous communities. The funding, delivered through its XXIII Convocatoria de Ayudas a la Investigación Médica, brings the foundation's total investment in medical research to nearly 75 million euros since its inception Source: elmundoes.
Two collaborative studies—involving teams from at least four autonomous communities each—stand out. The first, RISCATEA, led by Montse Fernández Prieto at the IDIS in Santiago de Compostela, will analyze 800 participants aged 12–30 to identify clinical, psychosocial, and genetic factors linked to suicide risk in people with autism spectrum disorder (ASD). Existing data indicate that 15% of individuals with ASD have attempted suicide and 37% have experienced suicidal ideation Source: abces. The second study, coordinated by Rodrigo Alonso Moralejo at Hospital 12 de Octubre in Madrid, examines telomere shortening in lung transplant recipients. The hypothesis is that shorter telomeres correlate with poorer prognosis after transplantation Source: elmundoes.
Both projects represent a push toward predictive tools that could assist clinicians without replacing their judgment Source: elmundoes.
“El 15% de las personas con trastorno del espectro autista (TEA) ha intentado suicidarse alguna vez, y el 37% ha tenido algún tipo de ideación suicida.”
“Los estudios realizados hasta el momento reflejan cifras alarmantes: el 15% de las personas con TEA han intentado suicidarse en alguna ocasión y el 37% ha tenido algún tipo de idea suicida.”
“La Fundación Mutua Madrileña ha entregado hoy sus XXIII Ayudas a la Investigación Médica, dotadas con 2,3 millones de euros, a 21 nuevos proyectos que se llevarán a cabo en hospitales de toda España.”
“Nuestra hipótesis es que la existencia de un acortamiento telomérico se vincula con un pronóstico adverso respecto a los receptores que no lo presentan.”